Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant Schizophrenia

NCT00565175 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Jesper Ekelund

Collaborators